Arkolith/Insider Trading/UNCY/Form 4

Gupta Shalabh K.

CEO, DirectorUnicycive Therapeutics, Inc. (UNCY) · full profile →Form 4 · filed Jul 13, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
1 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 11, 2023Option exercise(M)105K——2.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 11, 2023Option exercise(M)115K——115K
Jul 11, 2023Option exercise(M)79K——79K
Jul 11, 2023Option exercise(M)72K——72K
Jul 11, 2023Option exercise(M)50$1000.00—0

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-23-056848) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Unicycive Therapeutics, Inc.

Build

Ask your agent about UNCY insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001213900-23-056848"
Ask your agent
Use Arkolith to summarize insider buying and selling at Unicycive Therapeutics, Inc.
over the last 90 days and cite the filings.